Ending HIV in Europe - Can the EU lead the path forward to 2030?

Tuesday, 1 October 2024 | 10:30 - 11:45 CET

In recent decades, significant progress has been made in the fight against the Human Immunodeficiency Virus (HIV). Europe has committed to end the HIV epidemic by 2030.

However, many countries – including in Europe – are not on track to meet the global goals. HIV continues to pose a public health threat in the EU/EEA countries. Advocates have been calling for stronger actions at EU and national levels to end the HIV epidemic in Europe.

A new report published by BCG (commissioned by Gilead Sciences), “Going the extra mile to end the HIV epidemic”, lays out the need for sustained funding and investment in HIV prevention, innovation, and other policy efforts such as adopting a range of testing options.

Significant progress has been made in the fight to end the HIV epidemic, but we are currently at risk of falling short of the 2030 targets. Just 5 years out from 2030, join this Euractiv Hybrid Conference to discuss the actions needed to end the HIV epidemic in the EU.

Confirmed panellists:

Marc Angel MEP, Quaestor, Member of the Informal Working Group on HIV, UNAIDS Red Ribbon Leader, European Parliament
Julia del Amo, Director, Division for the control of HIV, STI, Viral Hepatitis and Tubercolosis, General Directorate of Public Health, Spanish Ministry of Health
Nicoletta Policek,Executive Director, European AIDS Treatment Group
Mercy Shibemba MBE, Co-author of the 'The Going the Extra Mila to End the HIV Epidemic Report' prepared and researched by Boston Consulting Group and commissioned by Gilead Sciences
Neil Mulcock, VP International Government Affairs, Gilead

More to be announced soon.

Find out more.